BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Dec 27, 2025; 17(12): 110764
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.110764
Clinical study on the efficacy of laparoscopic hepatectomy via the retroperitoneal approach for treating liver tumors
Zhen-Hao Fei, Xing-Fu Duan, Li-Hong Feng, Ze-Ning Wang, Ye-Sheng Chen, Zhi-Wei Sun
Zhen-Hao Fei, Xing-Fu Duan, Ze-Ning Wang, Ye-Sheng Chen, Zhi-Wei Sun, Department of Hepatopancreatobiliary Surgery, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming 650032, Yunnan Province, China
Li-Hong Feng, Yunnan University of Chinese Medicine, Kunming 650051, Yunnan Province, China
Author contributions: Fei ZH and Chen YS designed the clinical trial study; Duan XF and Feng LH implemented the study; Fei ZH and Duan XF were in charge of writing; Feng LH and Wang ZN translated the paper; Sun ZW supervised the entire research process and provided suggestions.
Supported by Yunnan Provincial Clinical Medicine Center for Digestive System Diseases, No. 2024YNLCYXZX0132.
Institutional review board statement: This study has been reviewed and approved by the local ethics review committee.
Clinical trial registration statement: This study has been registered with the Clinical Hospital Center Trial Registry.
Informed consent statement: All the individuals who participated in this study provided their written informed consent prior to study enrolment.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Data sharing statement: Consent to data sharing.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhi-Wei Sun, Professor, Department of Hepatopancreatobiliary Surgery, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, No. 157 Jinbi Road, Kunming 650032, Yunnan Province, China. 2833570686@qq.com
Received: June 16, 2025
Revised: July 8, 2025
Accepted: November 14, 2025
Published online: December 27, 2025
Processing time: 195 Days and 18.1 Hours
Abstract
BACKGROUND

Laparoscopic hepatectomy has been widely accepted for the treatment of liver tumors. Compared with open surgery, it provides a reduced hospital stay, less intraoperative blood loss, less trauma, and fewer incisional infections, without affecting tumor outcomes. However, lesions in the right lobe of the liver are deep and obstructed by the ribs, making exposure difficult and increasing the degree of surgical difficulty; thus, liver tumors in the deep right lobe pose technical challenges in standard laparoscopic surgery.

AIM

To investigate the safety and efficacy of laparoscopic retroperitoneal partial hepatectomy for liver tumors.

METHODS

The clinical data of 72 patients who underwent laparoscopic retroperitoneal partial hepatectomy for liver tumors between January 2018 and December 2024 at the First People’s Hospital of Yunnan Province were analyzed. Of the 72 patients included, 34 were male and 38 were female, with ages ranging from 34 years to 72 years (median age, 45 years). The tumors were all located in the right lobe of the liver, with 30 cases in segment S6, 27 cases in segment S7, and 15 cases in segment S8; the mean tumor diameter was 7.5 ± 3.4 cm. The postoperative tumor indices, liver function, and postoperative complications were analyzed to evaluate the clinical efficacy of laparoscopic partial hepatectomy via the retroperitoneal approach.

RESULTS

The surgeries were successfully completed in all patients, and conversion to open surgery was required in 10 patients. The mean operative time, blood loss, drain retention time, and length of postoperative hospital stay were 140 ± 30 minutes, 150 ± 46 mL, 3.8 ± 1.2 days, and 8.3 ± 5.3 days, respectively. Liver function tests returned to normal in all patients within two weeks of surgery. Fifteen patients developed atelectasis and pleural effusion and were managed with incision and drainage and antibiotics. Two patients developed uncomplicated minimal ascites, and the remaining patients had no perioperative complications, such as abdominal hemorrhage, infection, liver failure, bile leakage, and other adverse events. All patients were successfully treated.

CONCLUSION

Laparoscopic retroperitoneal partial hepatectomy is a safe and effective approach for right hepatic space-occupying lesions, particularly in segments S6, S7, and S8, with fewer postoperative complications, less trauma, and faster recovery times. This procedure provides a new surgical access for resection of deep tumors in the right lobe of the liver and has clear clinical implications.

Keywords: Liver tumor; Retroperitoneal approach; Laparoscopy; Partial hepatectomy

Core Tip: Laparoscopic retroperitoneal partial hepatectomy is a safe and effective approach for right hepatic space-occupying lesions, particularly in segments S6, S7, and S8, with fewer postoperative complications, less trauma, and faster recovery times.